The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according to a recent review article.
A study led by Roswell Park provides new insight into the complex interactions of the "tumor-immune-gut axis," and its role in influencing immunotherapy responses in patients with recurrent ovarian ...
Clearance for Use in the U.S. XBeam technology streamlines radiotherapy treatment planning and simplifies patient workflow for treating skin cancer, benign diseases, and palliative care. XBeam is the ...
Research suggests that some AI-generated mammographic features are indicative of early malignancy that is undetectable by radiologist-read mammography, while others may be benign conditions associated ...